Drosophila 14-3-3ε has a crucial role in anti-microbial peptide secretion and innate immunity

Tetyana Shandala1, Joanna M Woodcock, Yeap Ng

  • 1Division of Human Immunology, Centre for Cancer Biology, Adelaide SA5000, Australia. Tetyana.Shandala@unisa.edu.au

Insights

The study reveals that Drosophila 14-3-3ε is crucial for innate immunity by regulating antimicrobial peptide secretion. Mutants show impaired Drosomycin release due to defective vesicle transport, highlighting 14-3-3ε

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Antimicrobial peptides are vital for innate immunity, but their secretion mechanisms are not fully understood.
  • 14-3-3 proteins are known regulators of cellular processes, yet their role in immune effector release is unclear.

Purpose of the Study:

  • To investigate the role of Drosophila 14-3-3ε in innate immunity and antimicrobial peptide secretion.
  • To elucidate the molecular mechanism controlling the release of antimicrobial peptides from immune cells.

Main Methods:

  • Utilized Drosophila 14-3-3ε mutants and RNA interference (RNAi) for gene silencing.
  • Analyzed antimicrobial peptide (Drosomycin) release and localization using microscopy and vesicle tracking (Rab4, Rab11).

Main Results:

  • 14-3-3ε mutants exhibited reduced survival and impaired Drosomycin release upon bacterial infection.
  • Drosomycin-containing vesicles accumulated near the plasma membrane in 14-3-3ε mutants, indicating a transport defect.
  • 14-3-3ε interacts with Rab11 and Syntaxin 1a (Syx1a) on vesicles, suggesting a role in vesicle trafficking.

Conclusions:

  • 14-3-3ε is essential for the innate immune response in Drosophila by regulating antimicrobial peptide secretion.
  • The protein is required for the proper function of Rab11-positive vesicles involved in Drosomycin transport to the plasma membrane.
  • This study uncovers a novel molecular pathway for antimicrobial peptide release, involving 14-3-3ε, Rab11, and Syx1a.